Escucha el podcast NewsRamp Psychedelics Podcast

Optimi Health Corp. Ibogaine Initiative	NewsRamp Psychedelics Podcast	01:22
Psychedelic Therapy Companies Embrace White House Executive Order	NewsRamp Psychedelics Podcast	02:07
Advancements in Stress and Depression Treatments in Europe and U.S.	NewsRamp Psychedelics Podcast	01:55
FDA to Review NRX-100 NDA for Depression Treatment	NewsRamp Psychedelics Podcast	02:17
Helus Pharma Appoints Jill Conwell as Chief People Officer	NewsRamp Psychedelics Podcast	01:28
Transforming Mental Health with IV Ketamine Therapy	NewsRamp Psychedelics Podcast	01:31
Pharma Companies Making Strategic Moves: NRx Pharmaceuticals Debt-Free & Cybin Inc. Transfers to Nasdaq	NewsRamp Psychedelics Podcast	02:55
Cybin Inc. Reports Strong Growth and Progress in Mental Healthcare Innovations	NewsRamp Psychedelics Podcast	02:58
Revolutionizing Mental Healthcare: Cybin Inc. Conference Call Overview	NewsRamp Psychedelics Podcast	01:57
Revolutionizing Mental Healthcare: Cybin Inc.'s Innovative Drug Development	NewsRamp Psychedelics Podcast	02:04
Global Psychedelic Week 2025: Uniting the World in Psychedelic Conversation	NewsRamp Psychedelics Podcast	03:02
Revolutionizing Mental Healthcare: Cybin Inc. to Present at 2025 Milken Institute Future of Health Summit	NewsRamp Psychedelics Podcast	01:59
Cybin Inc. Announces $175M Direct Offering for Mental Health Treatment Development	NewsRamp Psychedelics Podcast	02:11
Celebrate the Transformative Power of Psychedelics at Global Psychedelic Week 2025	NewsRamp Psychedelics Podcast	02:10
Global Psychedelic Week 2025: A Worldwide Exploration of Psychedelic Therapies and Perspectives	NewsRamp Psychedelics Podcast	02:02
Advancements in Preservative-Free Ketamine Therapies by NRx Pharmaceuticals	NewsRamp Psychedelics Podcast	01:56
FDA Approval Secured for Preservative-Free Ketamine: NRx Pharmaceuticals Expands Market Opportunity	NewsRamp Psychedelics Podcast	01:52
Uniting the World: Global Psychedelic Week 2025	NewsRamp Psychedelics Podcast	01:58
Advancements and Milestones in Neuropsychiatry Drug Development by Cybin Inc.	NewsRamp Psychedelics Podcast	02:16
Fireside Chat at TD Cowen's Summit with Cybin Inc. Executives	NewsRamp Psychedelics Podcast	02:08
Advancements in Mental Health Treatments: NRx Pharmaceuticals and Cybin Inc. Acquisitions and Developments	NewsRamp Psychedelics Podcast	02:48
Cybin Inc. Chief Business Officer to Speak at H.C. Wainwright Conference	NewsRamp Psychedelics Podcast	01:59
Fireside Chat with Cybin Inc.'s CMO at Cantor Global Healthcare Conference	NewsRamp Psychedelics Podcast	01:58
Leadership Changes and Treatment Advancements in Mental Health Companies	NewsRamp Psychedelics Podcast	02:58
Advancing Psilocybin Therapy: Psylutions Supports Rescheduling Efforts	NewsRamp Psychedelics Podcast	02:05
Empowering Growth for Ketamine & TMS Clinics: Strategic Partnership Announcement	NewsRamp Psychedelics Podcast	02:14
Cybin Inc. Receives Approval for Phase 3 Study of CYB003 in Australia	NewsRamp Psychedelics Podcast	02:14
NRx Pharmaceuticals Urges FDA to Ban Benzethonium Chloride from Ketamine Products	NewsRamp Psychedelics Podcast	02:11
Advancements in Incannex Healthcare Inc.: Positive Phase 2 Results and Strong Valuation Potential	NewsRamp Psychedelics Podcast	02:09
Cybin Inc. Reports Promising Results and Shareholder Meeting Summary	NewsRamp Psychedelics Podcast	01:53
Cybin Inc. Reports Q1 2025 Results and Progress in Depression and Anxiety Studies	NewsRamp Psychedelics Podcast	02:04
NRx Pharmaceuticals' HOPE Therapeutics(TM) Expands Network and Expertise with Acquisition of Dura Medical LLC	NewsRamp Psychedelics Podcast	02:17
Cybin Inc. Receives European Approval for Phase 3 Study on CYB003 for Major Depressive Disorder	NewsRamp Psychedelics Podcast	02:05
Revolutionizing Mental Healthcare: Cybin's CEO to Speak at Growth Conference	NewsRamp Psychedelics Podcast	02:00
Exploring Neuroplasticity in CNS Disorders with NRx Pharmaceuticals CEO	NewsRamp Psychedelics Podcast	02:07
Cybin Inc. Receives UK Approval for Phase 3 Trial in Depression	NewsRamp Psychedelics Podcast	02:05
NRx Pharmaceuticals Applies for FDA Priority Voucher for NRX-100	NewsRamp Psychedelics Podcast	01:56
Advancing FDA-Designated Therapies: NRx Pharmaceuticals Collaborates with IBN for Corporate Communications Strategy	NewsRamp Psychedelics Podcast	01:52
Psyence Biomedical Chief to Speak at Psychedelic Science 2025 Conference	NewsRamp Psychedelics Podcast	02:01
Advancements in Cybin Inc.'s Phase 3 Psychedelic Therapeutics Program	NewsRamp Psychedelics Podcast	02:02

Optimi Health Corp. Ibogaine Initiative

NewsRamp Psychedelics Podcast

01:22

Psychedelic Therapy Companies Embrace White House Executive Order

NewsRamp Psychedelics Podcast

02:07

Advancements in Stress and Depression Treatments in Europe and U.S.

NewsRamp Psychedelics Podcast

01:55

FDA to Review NRX-100 NDA for Depression Treatment

NewsRamp Psychedelics Podcast

02:17